Literature DB >> 198323

Virus induced diabetes and the immune system. I. Suggestion that appearance of diabetes depends on immune reactions.

F K Jansen, H Müntefering, W A Schmidt.   

Abstract

The participation of immune reactions in the EMC virus induced diabetes of the mouse was studied by immunosuppression with 500 R sublethal X-irradiation or 120 mg/kg Asta 5122, a cyclophosphamide derivative. Average glucose levels after X-irradiation and infection remained normal, while virus, infected, otherwise untreated mice, had significantly higher mean glucose levels, indicating that immune reactions are necessary for the development of virus induced diabetes. Immune suppression by the cyclophosphamide derivative led, in contrast, to a significantly increased mean glucose level and increased insulitis in comparison with the controls only infected. This indicates an important role of the cellular immune reaction, insulitis in the destruction of the islets.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 198323     DOI: 10.1007/bf01234511

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  12 in total

1.  Epidemiological background to diabetes.

Authors:  D R Gamble; K W Taylor
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1976

2.  Encephalomyocarditis virus hemagglutination-inhibition test using antigens prepared in HeLa cell cultures.

Authors:  J E CRAIGHEAD; A SHELOKOV
Journal:  Proc Soc Exp Biol Med       Date:  1961-12

3.  [Pathology of diabetes mellitus in the white mouse infected with EMC-virus. Histological, electronmicroscopical and quantitative morphological findings in the islets of Langerhans].

Authors:  H Müntefering
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1972

4.  [Effect of cyclophosphamide and other homologous oxazaphosphorine-2-oxides on transplantation-immunologic reactions].

Authors:  W Müller-Ruchholtz
Journal:  Arzneimittelforschung       Date:  1974-08

5.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

6.  HL-A antigens and diabetes mellitus.

Authors:  J Nerup; P Platz; O O Andersen; M Christy; J Lyngsoe; J E Poulsen; L P Ryder; L S Nielsen; M Thomsen; A Svejgaard
Journal:  Lancet       Date:  1974-10-12       Impact factor: 79.321

7.  Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide.

Authors:  J L Turk; D Parker; L W Poulter
Journal:  Immunology       Date:  1972-10       Impact factor: 7.397

8.  Differential effects of cyclophosphamide on the B and T cell compartments of adult mice.

Authors:  G D Stockman; L R Heim; M A South; J J Trentin
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

9.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

10.  Antibodies to pancreatic islet cells in insulin-dependent diabetics with coexistent autoimmune disease.

Authors:  A C MacCuish; W J Irvine; E W Barnes; L J Duncan
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

View more
  13 in total

1.  Biochemical and ultrastructural changes in A and B cells of the islets of Langerhans of mice infected with EMC virus.

Authors:  F Zaheer; S L Howell; K W Taylor; T J Coleman; D R Gamble
Journal:  Diabetologia       Date:  1979-07       Impact factor: 10.122

2.  The influence of the major histocompatibility complex (H-2) on experimental diabetes in mice.

Authors:  H Kromann; A Lernmark; B F Vestergaard; J Egeberg; J Nerup
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

3.  Photoinactivation of the encephalomyocarditis virus.

Authors:  H Teschner; W A Schmidt; H Müntefering
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

4.  In vivo administration of serum thymic factor (FTS) prevents EMC-D virus-induced diabetes and myocarditis in BALB/cAJcl mice.

Authors:  M Mizutani; M El-Fotoh; M Mori; K Ono; K Doi; A Awaya; Y Matsumoto; Y Matsumoto; T Onodera
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

Review 5.  Disordered cellular immunity in type I diabetes of man and the BB rat.

Authors:  J B Buse; R F Rowley; G S Eisenbarth
Journal:  Surv Immunol Res       Date:  1982

6.  Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes.

Authors:  S Madsbad
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

7.  Glycaemic control and suppressor cell activity in patients with insulin-dependent diabetes mellitus.

Authors:  K Buschard; S Madsbad; T Krarup; J Rygaard
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

8.  Alterations in immunological reactivity in encephalomyocarditis virus-induced murine diabetes. I. Defective primary IgM plaque forming cell responses to sheep erythrocytes: correction by islet cell transplantation.

Authors:  B S Handwerger; G Fernandes; T Riehm; J W Yoon; D E Sutherland; D M Brown
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

9.  Virus-induced diabetes mellitus in mice and the thymus-dependent immune system.

Authors:  K Buschard; N Hastrup; J Rygaard
Journal:  Diabetologia       Date:  1983-01       Impact factor: 10.122

10.  Depressed suppressor cell activity in patients with newly diagnosed insulin-dependent diabetes mellitus.

Authors:  K Buschard; S Madsbad; J Rygaard
Journal:  Clin Exp Immunol       Date:  1980-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.